BBHvsXLVETF Comparison
VanEck Biotech ETF (BBH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. BBH is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.08% for XLV. BBH is down -1.86% year-to-date (YTD) with -$4M in YTD flows. XLV performs worse with -6.44% YTD performance, and +$1.23B in YTD flows. Run a side-by-side ETF comparison of BBH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBH vs XLV performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH XLV | +1.88%-0.41% | -7.18%-8.42% | -1.86%-6.44% | +24.34%+6.83% | +15.09%+12.26% | -0.59%+26.85% |
| Flows | BBH XLV | -$2M-$74M | -$4M-$228M | -$4M+$1.23B | -$52M+$1.16B | -$188M-$4.33B | -$130M+$7.32B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH XLV | +20.75%+15.20% | +20.44%+15.80% | +18.72%+13.72% | +21.44%+14.58% |
| Max drawdown | BBH XLV | -10.45%-10.19% | -10.45%-10.19% | -22.78%-17.05% | -39.88%-17.05% |
| Max drawdown duration | BBH XLV | 87d54d | 87d54d | 440d444d | 1719d444d |
BBH | XLV | |
Last sale 4/27/2026 at 1:30 PM | $184.15 | $143.46 |
| Previous close 04/24/2026 | $185.67 | $144.18 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBH | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBH | XLV | |
|---|---|---|
| Last price | $184.15 | $143.46 |
| 1D performance | -0.82% | -0.50% |
| AuM | $365.13 M | $38.13 B |
| E/R | 0.35% | 0.08% |
BBH | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VanEck | State Street Investment Management |
| Benchmark | MVIS US Listed Biotech 25 Index | S&P Health Care Select Sector Index |
| N° of holdings | 21 | 56 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | December 16, 1998 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
